首页> 外国专利> METHOD FOR CREATING IMMORTALIZED HUMAN-DERIVED TUMOR VASCULAR ENDOTHELIAL CELLS, AND IMMORTALIZED HUMAN-DERIVED TUMOR VASCULAR ENDOTHELIAL CELLS

METHOD FOR CREATING IMMORTALIZED HUMAN-DERIVED TUMOR VASCULAR ENDOTHELIAL CELLS, AND IMMORTALIZED HUMAN-DERIVED TUMOR VASCULAR ENDOTHELIAL CELLS

机译:固定化人源性肿瘤血管内皮细胞的方法及建立人源化肿瘤血管内皮细胞的方法

摘要

[Problem] An objective of the present invention is to obtain immortalized human-derived tumor vascular endothelial cells which are useful in cell based experiments such as compound screening. [Solution] The present invention pertains to a method for creating a strain of immortalized tumor vascular endothelial cells by: performing cellular separation by cellular separation using magnetic beads and optionally selected flow cytometry on a cell suspension derived from tumor tissue comprising tumor vascular endothelial cells, thereby separating a cell group comprising CD31-positive cells; then combining subculturing of the separated cell group and flow cytometry to re-separate a cell group comprising CD31-positive cells; transforming the cell group by using a viral vector that can express SV40T genes, hTERT genes, and genes capable of coding fluorescent protein; and combining subculturing and flow cytometry to isolate transformed cells. The present invention makes it possible to stably provide large quantities of tumor vascular endothelial cells useful for the screening of drugs and for the development of pharmaceuticals specifically for tumor vascular endothelial cells.
机译:[问题]本发明的目的是获得永生化的人源性肿瘤血管内皮细胞,其可用于基于细胞的实验例如化合物筛选。 [解决方案]本发明涉及通过以下方法产生永生化的肿瘤血管内皮细胞株的方法:使用磁珠通过细胞分离进行细胞分离,以及对包含肿瘤血管内皮细胞的肿瘤组织衍生的细胞悬液进行选择的流式细胞术,从而分离出包含CD31阳性细胞的细胞群;然后将分离的细胞群的传代培养与流式细胞术相结合以重新分离包含CD31阳性细胞的细胞群。通过使用可以表达SV40T基因,hTERT基因和能够编码荧光蛋白的基因的病毒载体来转化细胞群;并结合传代培养和流式细胞术以分离转化的细胞。本发明使得可以稳定地提供大量的肿瘤血管内皮细胞,其可用于药物筛选和用于开发专门用于肿瘤血管内皮细胞的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号